Impel Snags $750K Grant

6/24/11Follow @xconomy

Seattle-based Impel Neurpharma, the developer of technology to deliver drugs to the brain, said today it has secured a two-year, $750,000 grant from the U.S. Department of Defense. The company, a University of Washington spinout, previously got a $500,000 grant from the National Institutes of Health to support its method for delivering drugs through the upper nasal cavity, bypassing the blood-brain barrier, which limits the effectiveness of many neurological drugs. For more on Impel and its technology, check this profile from August 2008, when the company was getting going.

By posting a comment, you agree to our terms and conditions.